We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Simcere

News List

Simcere and Shanghai Institute of Materia Medica Enter a Collaboration to Jointly Develop Next-Gen COVID-19 Oral Antiviral Treatments prnasia
November 23, 2021
On November 17, 2021, Simcere Pharmaceutical Group Limited (2096.HK) announced that the company has reached collaboration agreement with the Shanghai Institute of Materia Medica (SIMM)...
Amgen, Simcere to Co-Develop and Commercialize Biosimilars in China americanpharmaceuticacreview
September 28, 2017
Amgen and Simcere Pharmaceutical Group announced the execution of an exclusive agreement to co-develop and commercialize four biosimilars in China.
Amgen and Simcere announce strategic collaboration to co-develop and commercialize biosimilars in Ch worldpharmanews
September 28, 2017
Amgen (NASDAQ: AMGN) and Simcere Pharmaceutical Group have announced the execution of an exclusive agreement to co-develop and commercialize four biosimilars in China.
Simcere, Amgen to bring in 4 biosimilars to China biospectrumasia
September 28, 2017
Amgen will remain responsible for the co-development, marketing approval applications and manufacturing of the biosimilars. Simcere will be responsible for distribution and commercialization in China